Status:

UNKNOWN

Tui-na and Oral Chinese Medicine on KOA

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Knee Osteoarthritis

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The study aims to evaluate the therapeutic effect of the Tui-na and oral Chinese medicine on the treatment of KOA. This is a prospective, randomized wait-list controlled trial in patients with knee o...

Detailed Description

The subjects will come for a screening visit at week 0 (baseline), then at week 2, week 4, and week 8 for Chinese medicine practitioner (CMP) investigators assessments. The Western Ontario and McMaste...

Eligibility Criteria

Inclusion

  • of either gender (female must have either sterilization done or menopause)
  • ≥50years of age
  • meet the criteria of KOA according to the American College of Rheumatology
  • Knee pain, and
  • Any 4 of the following,
  • ≥ 50 years of age
  • Less than 30 minutes of morning stiffness
  • Crepitus on active motion
  • Bony tenderness
  • Bony enlargement
  • No palpable warmth of synovium
  • Osteophytes (Radiographic findings)
  • with WOMAC score ≥ 39
  • with written informed consentform signed (for illiterate subjects, their next-of-kin or an impartial witness will sign with subjects' permission)

Exclusion

  • Known knee pain caused by infection, malignant or autoimmune diseases
  • Knee surgery or arthroscopy in the past year
  • Chondroprotective or intra-articular injection in the past 4 months
  • Systemic corticoid treatment in the past 4 months
  • Taking anticoagulants, antiplatelets, corticosteroids, psychiatric drugs, hormones, antiarrhythmic drugs or diuretics drugs
  • Subject with uncontrolled hypertension
  • Local antiphlogistic treatment, acupuncture, physiotherapy in the past 2 weeks
  • Known history of mental disorder
  • Known history of serious acute organic disease
  • Renal or liver function impairment
  • Known allergy to or have drug interaction with the study herb

Key Trial Info

Start Date :

September 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04492670

Start Date

September 14 2020

End Date

March 1 2023

Last Update

June 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Chinese University of Hong Kong

Hong Kong, Hong Kong